A phase III randomized trial of LV5FU2 + CPT-11 vs. LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) - Ychou,M.; Raoul,J.; Douillard,J. (Proc Am Soc Clin Oncol, 2005)